Arcellx, Inc.
- Raised $100 million (2023)
- 5 clinical trials, 5 active
- Founded 2014
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Compugen Ltd
Nasdaq: CGEN
- Raised $20 million (2021)
- 5 clinical trials, 2 active
Corvus Pharmaceuticals, Inc.
Nasdaq: CRVS
- Raised $75 million (2015)
- 11 clinical trials, 4 active
- Founded 2014
CytoSite BioPharma Inc.
- Raised $3 million (2020)
- 3 clinical trials, 1 active
- Research grants: $3.6 million
- Founded 2016
Edesa Biotech, Inc.
Nasdaq: EDSA
- Raised $3.5 million (2026)
- 6 clinical trials, 4 active
- Founded 2007
Gain Therapeutics, Inc.
Nasdaq: GANX
- Raised $10 million (2020)
- 2 clinical trials, 2 active
- Founded 2020
ImCare Biotech, Inc.
- Raised $153,402 (2023)
- 1 clinical trial, 1 active
- Research grants: $13 million
Nomad Power Solutions, Inc.
Nasdaq: NMAD
- Raised $3.5 million (2023)
- 2 clinical trials, 1 active
- Founded 2005
Odyssey Therapeutics, Inc.
Nasdaq: ODTX
- Raised $214 million (2025)
- 2 clinical trials, 1 active
- Founded 2021
Outlook Therapeutics, Inc.
Nasdaq: OTLK
- Raised $5 million (2024)
- 5 clinical trials, 1 active
Sano Chemicals Inc
- Raised $710,000 (2024)
- 1 clinical trial, 1 active
- Research grants: $8.3 million
Scilex Holding Co
Nasdaq: SCLX
- Raised $2.7 million (2025)
- 2 clinical trials
- Founded 2020
Senti Biosciences, Inc.
- Raised $39 million (2018)
- 1 clinical trial, 1 active
- Research grants: $2.4 million
- Founded 2016
Septerna, Inc.
Nasdaq: SEPN
- Raised $73 million (2023)
- 2 clinical trials, 1 active
- Founded 2019
Solenic Medical, Inc.
- Raised $3.2 million (2024)
- 1 clinical trial, 1 active
- Research grants: $2.7 million
- Founded 2019
Valion Bio, Inc.
Nasdaq: VBIO
- Raised $12 million (2025)
- 2 clinical trials
- Founded 2016
Vesteck, Inc.
- Raised $2.3 million (2023)
- 1 clinical trial
- Research grants: $3.4 million
- Founded 2019
Vigilant Biosciences, Inc.
- Raised $17 million (2019)
- 1 clinical trial
- Research grants: $438,908
- Founded 2011
Vitro Biopharma, Inc.
- Raised $100,000 (2025)
- 2 clinical trials
- Research grants: $100,000
Vixiar Medical, Inc.
- Raised $1.6 million (2018)
- 3 clinical trials
- Research grants: $2.6 million
- Founded 2013
Workit Health, Inc.
- Raised $75 million (2021)
- 1 clinical trial
- Research grants: $852,543
- Founded 2015
Zura Bio Ltd
Nasdaq: ZURA
- Raised $112 million (2024)
- 2 clinical trials, 2 active
- Founded 2021
Aerin Medical Inc.
- Raised $32 million (2024)
- 15 clinical trials, 3 active
- FDA-cleared or approved devices
- Founded 2011
Bright Cloud International Corp
- 7 clinical trials
- 1 FDA-registered device site
- Research grants: $6.1 million
Keranetics LLC
- Raised $2.2 million (2018)
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $1 million
Xenex Disinfection Services LLC
- Raised $4.8 million (2018)
- FDA-cleared or approved devices
- Research grants: $2.2 million
- Founded 2009
Stingray Therapeutics, Inc.
- Raised $25,000 (2024)
- 2 clinical trials, 2 active
- Research grants: $8.4 million
- Founded 2018
Epitel, Inc
- 3 clinical trials
- FDA-cleared or approved devices
- Research grants: $32 million
Calcivis Ltd
- Raised $792,002 (2018)
- 3 clinical trials
- FDA-cleared or approved devices
- Founded 2011
Geron Corp
Nasdaq: GERN
- 17 clinical trials, 4 active
- Research grants: $806,859
NeuroVision Imaging, Inc.
- Raised $11 million (2018)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $150,874
QTREX Quantum Ltd.
Nasdaq: QTEX
- Raised $8.3 million (2025)
- FDA-cleared or approved devices
Astrazeneca plc
NYSE: AZN
- 2 FDA-registered drug sites
- Founded 1992
Biomea Fusion, Inc.
Nasdaq: BMEA
- Raised $56 million (2021)
- 9 clinical trials, 3 active
- Founded 2017
BioStem Technologies, Inc.
Nasdaq: BSEM
- Raised $2.5 million (2026)
- 4 clinical trials, 1 active
Crescent Biopharma, Inc.
Nasdaq: CBIO
- Raised $39 million (2010)
- 20 clinical trials, 1 active
Erasca, Inc.
Nasdaq: ERAS
- Raised $125 million (2020)
- 10 clinical trials, 5 active
- Founded 2018
Iterum Therapeutics plc
OTC: ITRMF
- Raised $2.8 million (2020)
- 9 clinical trials, 1 active
- Founded 2015
Lipocine Inc.
Nasdaq: LPCN
- Raised $38 million (2013)
- 9 clinical trials, 1 active
- Founded 2011
Nkarta, Inc.
Nasdaq: NKTX
- Raised $44 million (2019)
- 4 clinical trials, 4 active
Oruka Therapeutics, Inc.
Nasdaq: ORKA
- Raised $52 million (2015)
- 19 clinical trials, 6 active
Palisade Bio, Inc.
Nasdaq: PALI
- Raised $4 million (2024)
- 4 clinical trials, 1 active
Sagimet Biosciences Inc.
Nasdaq: SGMT
- Raised $69 million (2021)
- 9 clinical trials, 1 active
- Founded 2006
TScan Therapeutics, Inc.
Nasdaq: TCRX
- Raised $100 million (2021)
- 9 clinical trials, 5 active
- Founded 2018
Turning Point Therapeutics, Inc.
- Raised $80 million (2018)
- 9 clinical trials, 3 active
- Founded 2013
Puma Biotechnology, Inc.
Nasdaq: PBYI
- Raised $5 million (2011)
- 38 clinical trials, 3 active
- Founded 2007
BioLineRx Ltd.
Nasdaq: BLRX
- Raised $9 million (2020)
- 19 clinical trials, 1 active
Anaptysbio, Inc
Nasdaq: ANAB
- Raised $41 million (2015)
- 8 clinical trials, 2 active
- Founded 2005
BioRestorative Therapies, Inc.
- Raised $1.4 million (2025)
- 1 clinical trial, 1 active
- Research grants: $1 million
Innate Pharma SA
Nasdaq: IPHA
- Raised $27 million (2014)
- 18 clinical trials, 3 active
Published company profiles only; counts update daily. Data licences